“With Angelman syndrome, not every child presents the same,” he says. “It's a broad spectrum of characteristics that come ...

We performed a single-arm open-label trial in which 25 children diagnosed with Angelman syndrome (AS) were administered minocycline to assess the safety and tolerability of minocycline in this ...

that as father to his two children. The charismatic actor loves both of his sons, and has recently opened up about his eldest ...

Purpose: Considering cost as a factor, the authors evaluated three approaches to the diagnostic testing of Prader-Willi syndrome (PWS) and Angelman syndrome (AS). Methods: The approaches evaluated ...

Ionis has announced the design for a Phase III trial of ION582, a treatment for Angelman syndrome (AS), following discussions with the FDA.

A child with Angelman syndrome – which affects around one in 21,000 births worldwide – will typically begin to show signs of delayed development at around six to 12 months. There are no ...

Considering taking supplements to treat angelman syndrome? Below is a list of common natural remedies used to treat or reduce the symptoms of angelman syndrome. Follow the links to read common ...

But they’ve all done so with the goal of helping to treat their children’s rare diseases ... chief scientific officer at the Foundation for Angelman Syndrome Therapeutics.

Ultragenyx Pharmaceutical (NASDAQ:RARE) announced Saturday that GTX-102, its candidate for the rare neuro-genetic disorder Angelman syndrome, improved patient outcomes across multiple domains in a ...

"Children suffering from Angelman syndrome will always need support with different parts of their lives, so playing my role in helping them has really driven me on and I’m delighted I’ve ...

A four-year-old girl with DUP15q syndrome, who doctors said would never walk, has defied expectations to take her first steps.

(RARE) announced Phase 1/2 data in support of the Phase 3 Aspire study for GTX-102, its investigational antisense oligonucleotide for Angelman syndrome. The Phase 1/2 data showed improvements ...